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Abstract
Background: 3′untranslated regions (3′UTRs) are poorly understood portions of eukaryotic mRNAs essential for
post-transcriptional gene regulation. Sequence elements in 3′UTRs can be target sites for regulatory molecules such
as RNA binding proteins and microRNAs (miRNAs), and these interactions can exert significant control on gene
networks. However, many such interactions remain uncharacterized due to a lack of high-throughput (HT) tools to
study 3′UTR biology. HT cloning efforts such as the human ORFeome exemplify the potential benefits of genomic
repositories for studying human disease, especially in relation to the discovery of biomarkers and targets for
therapeutic agents. Currently there are no publicly available human 3′UTR libraries. To address this we have
prepared the first version of the human 3′UTRome (h3′UTRome v1) library. The h3′UTRome is produced to a single
high quality standard using the same recombinational cloning technology used for the human ORFeome, enabling
universal operating methods and high throughput experimentation. The library is thoroughly sequenced and
annotated with simple online access to information, and made publically available through gene repositories at low
cost to all scientists with minimal restriction.
Results: The first release of the h3′UTRome library comprises 1,461 human 3′UTRs cloned into Gateway® entry
vectors, ready for downstream analyses. It contains 3′UTRs for 985 transcription factors, 156 kinases, 171 RNA binding
proteins, and 186 other genes involved in gene regulation and in disease. We demonstrate the feasibility of the h3′
UTRome library by screening a panel of 87 3′UTRs for targeting by two miRNAs: let-7c, which is implicated in
tumorigenesis, and miR-221, which is implicated in atherosclerosis and heart disease. The panel is enriched with genes
involved in the RAS signaling pathway, putative novel targets for the two miRNAs, as well as genes implicated in
tumorigenesis and heart disease.
Conclusions: The h3′UTRome v1 library is a modular resource that can be utilized for high-throughput screens to
identify regulatory interactions between trans-acting factors and 3′UTRs, Importantly, the library can be customized
based on the specifications of the researcher, allowing the systematic study of human 3′UTR biology.
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Background
3′untranslated regions (3′UTRs) are the sequences lo-
cated immediately downstream of from the STOP codon
of mature mRNAs. Although historical attention focused
on protein coding sequences and upstream regions, 3′
UTRs have recently become subject to intense study be-
cause they are targets of a variety of regulatory molecules,
including RNA binding proteins (RBPs) and small non-
coding RNAs (ncRNAs), that recognize small cis-elements
present in the 3′UTRs. These cis-elements play critical
roles in deciding the fate of the mRNA via various mecha-
nisms, including co-transcriptional processing, modulating
protein translation, mRNA localization and trafficking,
and mRNA degradation and stability [1]. Disruption of
these processes is known to affect diverse developmental
and metabolic processes, and contributes to various dis-
eases, including neurodegenerative diseases, diabetes, and
cancer [2–5].
RBPs play a role in every aspect of mRNA biogenesis,
such as stability, localization, translation and decay. The
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human transcriptome contains approximately ~400 pro-
teins with distinguishable RNA binding domains [6], and
their deregulation is linked to major neurodegenerative
disorders, cancer, and muscular dystrophies. Compared
to transcription factors, which generally bind highly spe-
cific linear DNA sequence elements, elements in 3′UTRs
targeted by RBPs are generally more degenerate and diffi-
cult to identify bioinformatically because RNA is a single-
stranded molecule and RBP binding is mostly dictated by
local folding and polarity [6]. Consequently, RBPs have
the potential to bind to multiple elements in different 3′
UTRs, leading to intricate, dynamic, and mostly unknown
networks of RNA-protein interactions.
3′UTRs are also targeted by a class of post-transcrip-
tional regulators known as microRNAs (miRNAs), which
are short non-coding RNAs that bind to complementary
sequences in the 3′UTRs of metazoans [1]. Once bound,
based on the degree of complementarity, miRNAs can in-
duce either translational repression or mRNA degradation
[7]. MiRNAs canonically recognize targets in 3′UTRs via
Watson-Crick base pairing, requiring complementarity
with as few as six consecutive nucleotides between the 5′
end of a mature miRNAs and the 3′UTR of a target tran-
script [7]. However, recent evidence suggest that miRNAs
do not require perfect complementarity with target 3′
UTRs to induce functional translational repression, and
non-canonical interactions are frequent [8]. Because
miRNA target elements are degenerate and small they are
difficult to detect, thus a vast majority of biologically rele-
vant miRNA targets are still unknown. Based on bioinfor-
matic predictions of miRNA-binding sites in 3′UTRs, it
has been proposed that each miRNA controls large net-
works of hundreds of mRNAs [9]. However, recent ana-
lysis of the predictive performance of several of the most
prominent prediction algorithms, such as TargetScan
[10], PicTar [11] and DIANA-microT [12] report ex-
tremely high false negative rates [8, 13, 14]. While these
algorithms are very useful for candidate gene approaches
to identify miRNA targets, the extremely high error rates
make high-throughput target detection challenging.
Coupled with the absence of a publically available and
comprehensive 3′UTR library, the field currently lacks
tools to systematically study miRNA targets, which is the
gold standard in miRNA biology.
Several genomic resources are currently available to
systematically study gene expression and its regulation
in humans. The human ORFeome for example, is a
collection of over 12,000 human protein-coding genes
cloned in modular vectors and optimized to study the
dynamics of gene expression [15, 16]. The ORFeome has
been used to characterize genome wide protein-protein
interaction networks, leading to important discoveries
relevant to human disease [15]. HT resources such as
this can significantly advance our understanding of gene
functions in multicellular organisms. Unfortunately, such
a standardized HT tool to detect and study regulatory
elements in 3′UTRs are not available since 3′UTR se-
quences are not present in the ORFeome. Some indi-
vidual 3′UTR clones are available commercially, but
these products have sporadic coverage, are too expen-
sive for HT studies, use only proprietary vectors and
are not compatible with the ORFeome. Furthermore,
endogenous full length 3′UTRs frequently undergo al-
ternative processing in a tissue specific fashion [17],
which limits the biological relevance of experiments
that use truncated or partial 3′UTRs.
To overcome this limitation, a recent study used
~240,000 short RNA sequences containing all pos-
sible 9-base nucleotide permutations immobilized on
microarrays to study the binding requirements of 205
human RBPs [6]. Although this work and others high-
lights important binding properties of RBPs, they do not
necessarily reflect biological settings, where accessory ele-
ments near binding sites that may cooperate with the RBPs
targeting are not present.
Recently, our group experimented with the usage of a
pilot human full length 3′UTR library to detect miRNA
targets in 3′UTRs using a scalable dual-luciferase assay
named Luminescent Identification of Functional Elements
in 3′UTRs (3′LIFE) [8, 18]. Although we cloned and
screened only ~300 query 3′UTRs, the proof of principle
3′LIFE screen was highly effective at the rapid and
efficient discovery of many novel targets for two can-
cer relevant miRNAs, let-7c and miR-10b [8]. This
pilot screen demonstrated the value of such an un-
biased HT approach, and supports the need for the de-
velopment of a publically available genome wide 3′
UTR library.
Furthermore, there is a critical need in the field for a
high-quality and standardized human 3′UTR resource,
which could be widely used in the community to study
miRNAs and RBPs using full length 3′UTRs in unbiased
and HT experiments.
To overcome these limitations, we have developed the
first publically available and high-quality human 3′UTR
clone library, sequenced verified and cloned in modular
vectors amenable to various downstream analyses. This
resource enables the systematic study of 3′UTR biology,
can be used to efficiently detect miRNA and RBP targets
at high resolution, and study mRNA localization and
dynamics. In the context of disease states, this library
allows the study of key disease alterations in post-
transcriptional processing, such as disease-specific: 1)
mRNA mislocalization, 2) alternative polyadenylation, 3)
altered miRNA expression, 4) mutation of RNA binding
protein elements in 3′UTRs, and 5) more generally, the
contribution of post-transcriptional gene regulation to
gene output in disease initiation and progression.
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Results and discussion
The human 3′UTRome v1 clone collection (h3′
UTRome v1) consists of 1,461 unique, cloned and
sequence-validated human 3′UTRs from transcription
factors, kinases and other regulatory genes (Fig. 1a).
This collection is contained in modular Gateway®
compatible Entry vectors, is amenable for large
screens and is publically available to the community
through the at the DNASU plasmid repository
(https://dnasu.org/DNASU/Home.do).
Fig. 1 The human 3′UTRome cloning pipeline. a We targeted a panel of 1,815 unique human 3′UTRs and successfully cloned and sequence
verified 1,461 unique 3′UTRs (80.1 % cloning success). b The forward primers used to amplify 3′UTR genomic loci were anchored within the last
exon of each transcript, ending with the gene specific STOP codons. The reverse primers bound 150 nucleotides downstream of the annotated
transcript. c Flow chart summarizing the cloning pipeline of the h3′UTRome v1. Genomic PCR was performed using 3′UTR specific primers and
the PCR products were shuttled into Gateway® Entry vectors by recombinational cloning. Single cloned colonies were isolated and screened
based on the expected 3′UTR length using PCR and gel electrophoresis. Bacterial colonies passing the screen were then re-arrayed, and the
cloned 3′UTRs were sequenced using Sanger sequencing method. The sequence verified 3′UTRs were then submitted to the DNASU plasmid
repository for public distribution. 3′UTRs that were not successfully cloned were subject to a second pass of cloning. d Electrophoretic analysis of
PCR products from the complete h3′UTRome v1. The sizes of 3′UTRs from 1,461 PCR reactions were analyzed on ethidium bromide stained gels
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Primer design and genomic PCR
As a first release, we targeted and designed genomic primer
pairs encompassing the 3′UTR regions of 1,815 human
protein coding genes using the human genome release 19
(Additional file 1: Table S1) (GRCh37/hg19 Feb. 2009) [19].
The forward primers used for the genomic PCR were
designed to anneal within the last exon of the target
gene, ending with the gene-specific STOP codon in
frame with the rest of the transcript (Fig. 1b). This expe-
dient allowed us to increase the melting temperature of
each forward primer, since the G/C content drops con-
siderably after the STOP codon. In addition, designing
the forward primer within the open reading frame pro-
vides the 3′UTR with its natural gene-specific STOP
codon at its 5′end, allowing convenient in-frame inte-
gration with the human ORFeome library, which instead
lacks termination codons [16] (Fig. 1b). The melting
temperatures of the primers ranged from 50 to 76 °C.
Given this wide range of temperature we opted for a
touchdown genomic PCR approach, starting at 66 °C
and decreasing by 1 °C each cycle [8]. The reverse
primers were designed to target a genomic site 150 nt
downstream of the annotated transcript, encompassing
downstream elements that may play a role in mRNA 3′
end formation (Fig. 1b). We added the Gateway® recom-
bination elements attB2 (forward primers) and attB3 (re-
verse primers) to the 5′ends of the genomic primers, to
facilitate the cloning into Gateway® compatible Entry vec-
tors. A minimum of 200 ng of genomic DNA per reaction
was required to obtain an enriched PCR product while
minimizing non-specific amplicons, which is known to im-
pact the recombinational cloning procedure. The complete
pipeline used in this study is shown in Fig. 1c.
Gateway® recombinational cloning
The full understanding of gene expression must consider
both transcriptional and post-transcriptional regulation, re-
quiring attention to the transcriptional promoter, the Open
reading frame (ORF) and the regulatory sites within the 3′
UTR.
The human 3′UTRs in this collection were cloned into
the pDONR P2r-P3 Gateway® Entry vector (Invitrogen)
using BP recombinant cloning. This vector is part of the
three-fragment Gateway® technology, which allows
modular cloning of a given promoter, an ORFeome entry
and correspondent 3′UTR to be assembled in order, into
a single vector in the same reaction. This allows investiga-
tors to combine these 3′UTRs with different ORFs (which
are already available in the ORFeome collection) to create
both natural and novel regulatory contexts. Current pro-
tein expression vectors typically rely on viral 3′UTRs,
such as the SV40 polyA, which often do not reflect natural
translational levels or post-transcriptional regulation. In
addition, the natural 3′UTR may contribute to proper
localization and stability. This technology is also compat-
ible with the 3′LIFE assay system and has been previously
used to screen for functional miRNA targeting in 3′UTRs
[8]. Successfully cloned colonies were isolated and grown
in LB and analyzed by colony PCR using primers specific
to the pDONR P2r-P3 backbone. The PCR amplicons
were analyzed by agarose gel electrophoresis and screened
based on the expected lengths of the 3′UTRs (Fig. 1d).
We observed an inverse correlation between the size of
the inserted 3′UTR and the BP cloning success rate
(Fig. 2a). A size bias during the BP cloning reaction has
been previously reported [20], with a decreased efficiency
for amplicons greater than 1,000 nt and in agreement with
our observations [20]. However 3′UTRs in the h3′
UTRome v1 are enriched with longer 3′UTR isoforms
and on average contain longer 3′UTRs than those within
the human transcriptome (Fig. 2b). The nucleotide lengths
of the human 3′UTR clones in this release span from
200 nt to 2,500 nt and have a median length of 1,159 nt,
as opposed to the median length of 3′UTRs within
the human genome, which is 1,040 nt (Fig. 2b, purple
and red arrows).
The first pass of cloning produced a yield of 1,410 bac-
terial colonies with PCR products of the expected size.
We performed a second pass on all 405 missed 3′UTRs
and gained an additional 172 3′UTRs, a 12 % increase to
the total number of size verified clones (Fig. 1c). The
complete size-verified first release of the h3′UTRome v1
is shown in Fig. 1d.
Sanger sequencing
A total of 1,582 size verified clones were subsequently se-
quenced using Sanger method using a custom primer an-
chored within the P2rP3 plasmid backbone. We used Perl
scripts to perform BLAT alignments [21] using the Sanger
trace files obtained during the sequencing. Our analysis
revealed that out of the initially targeted 1,815 unique 3′
UTRs, 1,461 were successfully sequence verified (~80 %
success rate from genomic PCR to sequence verification).
3′UTRome library overview
The human 3′UTR clones contained in the h3′UTRome
v1 are unbiased towards any particular regions of the
genome and correspond to ~6-10 % of the total protein-
coding genes present in each chromosome (Fig. 2c). The
source of DNA used for the genomic PCR was
GM12878, a lymphoblastoid cell line of female origin
recommended as a Tier 1 cell line by the ENCODE pro-
ject. Over 54 % of the 3′UTRs in the h3′UTRome v1
overlap with genes present in the hORFeome V8.1
(Fig. 2d) [16]. We targeted 971 3′UTRs of genes already
present in the ORFeome and successfully cloned 790 3′
UTRs (Fig. 2d). For this first release, we targeted pre-
dominantly 3′UTRs of genes previously classified as
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transcription factors [22, 23], kinases [24], and RBPs [25]
(Fig. 2e). We targeted the 3′UTRs of this class of genes
because they have widespread regulatory functions and
have corresponding ORFeome clones. The h3′UTRome
v1 release includes 3′UTRs for 985 transcription factors,
171 Kinases and 156 RBPs (Fig. 2e).
Library distribution
The h3′UTRome v1 library is distributed by the DNA
repository DNASU (https://dnasu.org/DNASU/Home.do),
a public plasmid repository hosted at the Biodesign
Institute at Arizona State University, which already distrib-
utes over 180,000 individual plasmids and full genome
Fig. 2 Overview of the human 3′UTRome v1 library. a Percentage of cloning success vs 3′UTR length. The efficiency of 3′UTR cloning (blue line)
decreases ~30 % beyond the length of 1,000 nucleotides in the cloned dataset (red). The maximum cloning efficiency for amplicons smaller than
499 nt was 92.8 %, while the cloning efficiency of 3′UTRs grater than 2,000nts was 64.3 %. b Length of the 3′UTRs of genes in the human genome hg19
vs the h3′UTRome v1. The 3′UTRs in the h3′UTRome v1 range between 200 nt to 2,500 nt, and are enriched for longer 3′UTR isoforms. The median length
of 3′UTRs in the h3′UTRome v1 is 1,159 nt (purple arrow) while in the human genome hg19 it is 1,040 nt (red arrow). c The h3′UTRome v1 contains 3′UTRs
for 6-10 % of the ORFs within each chromosome. None of the 3′UTRs cloned in this release originates from the Y chromosome, as the source of genomic
DNA used was of female origin. d The degree of overlap between the h3′UTRome v1 and the hORFeome V8.1. More than half of the 3′UTRs cloned in the
h3′UTRome v1 contain corresponding clones present in the hORFeome V8.1. e The h3′UTRome v1 (orange circle) is enriched for 3′UTRs of genes involved
with gene regulation as it contains predominantly 3′UTRs of transcription factors (33.9 %), kinases (40.8 %), and RNA binding proteins (32.4 %)
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collections, including the human ORFeome [26]. Users
can either search for a given 3′UTR clone, a plate or order
the complete dataset. Many researchers are not interested
in HT screens nor have the resources for large screens in
their departments, but want to detect miRNA targets, mu-
tations, or truncation of regulatory elements in the 3′UTR
of their gene of interest. These researchers will be able to
accelerate their research significantly because they can
now order the correct ORF, 3′UTR clones and the vectors
they need for their analysis at reduced cost. To simplify
the ordering procedure we have given a unique ID prefix
‘HSU’ to the human 3′UTRs available with this release.
3′LIFE validation screen
The 3′LIFE screen is a high throughput dual luciferase
assay, previously shown to detect functional repression
of test 3′UTRs by query miRNAs [8, 18]. The 3′LIFE
screen utilizes Gateway® cloning technology and is fully
compatible with the h3′UTRome v1. In order to demon-
strate the usability and functionality of this library we have
selected 87 human 3′UTRs from the h3′UTRome v1 li-
brary and screened for miRNA targets of two disease-
relevant miRNAs: let-7c and miR-221 using the 3′LIFE
assay [8, 18]. let-7c is a well-characterized tumor suppres-
sor gene, is down-regulated in many cancers, and is
known to target genes in the RAS pathway [27]. Con-
versely, miR-221 is frequently overexpressed in breast
cancer, hepatocellular carcinomas, glioblastoma and pros-
tate cancer [28–31], and has been shown to target several
tumor suppressor genes such as Kip-1 (p-27), CDKN1B,
CDKN1C, PTEN, ARHI and PUMA [29, 32, 33]. In
addition, miR-221 is known to be involved with muscle
damage repair and atherosclerosis [34, 35]. One of the
goals of this experiment was to use this 3′UTR library to
rapidly identify bona fide miRNA targets from false targets
predicted by miRNA targeting software. These programs,
such as TargetScan [10], PicTar [11] and DIANA-microT
[12] are known to have high false negative rates (~43 %)
[8, 13, 14] and false positive rates (~66 %) [8, 36, 37], and
cannot be used alone to definitively assign targets.
These 87 human 3′UTRs were enriched with let-7c
and miR-221 predicted and validated targets from all
three prediction softwares (9 predicted and 3 validated
targets for let-7c and 10 predicted and 9 validated tar-
gets for miR-221) (Additional file 2: Table S2). For the
let-7c screens, we also included two genes that contain
validated miRNA targets identified in a previous screen
[8]. In addition, since miRNAs preferentially target genes
within the same regulatory pathways [8], and let-7c was
previously shown to target the RAS family of genes
[8, 27], we were interested to test if let-7c could also
target additional 25 members of this pathway (Additional
file 2: Table S2), as defined by Gene Ontology [38] and
KEGG databases [39].
We shuttled these 87 human 3′UTRs from the h3′
UTRome v1 clone library into the 3′LIFE vector using
LR recombination reactions. Using this custom library,
we performed 435 fully automated transfections and dual
luciferase experiments. The results of the screen are
shown in Fig. 3. Using a cut-off for functionally repressed
targets at a repression index of 0.8 and a p-value <0.05, we
obtained 19 statistically significant hits for let-7c, and 13
for miR-221 (Fig. 3).
Our results validate 4 out of 9 of the let-7c targets
predicted by prediction softwares [10–12]. Within the
predicted hits, we detected all three previously validated
targets (CDC25A, TRIM71 and BCL2L1) and an unvalid-
ated, predicted target (RNF7) (Fig. 3 and Additional file 2:
Table S2). Furthermore we detected an additional 10 novel
and unpredicted targets for let-7c (Fig. 3 and Additional
file 2: Table S2). We found that one of these novel targets
PAK3, was predicted by the prediction algorithm miRanda
[40], which takes into account non-canonical seed interac-
tions. Of note, 3 targets within this group (MCM2, BUB1B
and GMNN) were previously correlated indirectly with
let-7 expression [41].
For miR-221, our results validated 4 out of 10 of the
miR-221 targets predicted by the prediction software
[10–12], and an additional 4 out of 9 of the targets pre-
viously validated by others (WEE1, ETS2, FMR1 and
KIT) (Additional file 2: Table S2) [42–45]. Interestingly,
we were unable to detect repression in 3′UTRs of 5
genes previously known to contain miR-221 responsive
elements (CDKN1C, FOS, IRF2, ICAM1, PAK1) [46–50].
Upon further review, we found that repression of all five
targeted elements was demonstrated using truncated sec-
tions of the 3′UTR. Thus, the observation that the 3′LIFE
screen did not detect these targets could be caused
by the inability of these elements to recruit miR-221
when expressed within their full length endogenous
3′UTRs, or by the presence of alternative polyadeny-
lation events that cause the lost of these elements [8].
Two targets of miR-221 called by the prediction software
[10–12] were also not detected as hits in our assay
(KHDRBS2 and RORB). We also discovered 9 novel and
unpredicted targets for miR-221 not anticipated by
major prediction software [10–12], or detected by
others. (Additional file 2: Table S2). Within this group,
FRAP1 was the only gene predicted by miRanda [40].
Perfect complementarity within the seed region is
considered the canonical indicator of miRNAs targeting.
Interestingly, most of these novel targets do not always
contain canonical seeds. Recent studies indicate that
miRNAs are also capable of recognizing non-canonical
elements in target mRNAs [8, 36, 51, 52], supporting
our findings.
Taken together, these experiments validate 9 out of 18
bioinformatically predicted targets [10–12] (50 % false
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positive rate), which is in accordance with the false posi-
tive rates of prediction algorithms reported in previous
studies [8, 13, 14, 36, 37]. In previous studies we used
repression data from the 3′LIFE assay to identify and
validate functional miRNA binding sites [8]. With experi-
mentally validated miRNA target sites, targeting signatures
Fig. 3 The h3′UTRome v1 as a resource to detect miRNA targets in high throughput. 3′LIFE screen performed on 87 human 3′UTRs extracted
from the h3′UTRome v1, queried against two miRNAs let-7c and miR-221. The repression index was calculated for each 3′UTR and indicates a
normalized ratio between Firefly and Renilla luciferases. A minimum cutoff for repression was drawn at 0.8 and the asterisks denote statistically
significant repression (p < 0.05). The top hits for each miRNA are displayed as a heat map on the right panels. Increased intensity of color
indicates greater repression. 18 top hits were identified for let-7c of which 3 were previously validated (as denoted by the arrows). 13 top hits
were identified for miR-221 of which 4 were previously validated (as denoted by the arrows)
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can be extrapolated to refine target predictions for
specific miRNAs.
Interestingly, while the 3′LIFE assay is designed to de-
tect repression of 3′UTRs by miRNAs, we detected
several 3′UTRs that significantly enhanced the expres-
sion of the luciferase reporter gene in the presence of
let-7c and miR-221 (Fig. 3). Perhaps these enhancements
are caused by increase stability of a given 3′UTR due
to direct or indirect interactions with the query miRNAs.
The ability to systematically screen large numbers
of human 3′UTRs allowed in depth analysis of high-
confidence target genes regulated by different miRNAs,
and may reveal novel mechanisms that miRNAs use to
regulate biological processes. For example, a gene ontol-
ogy analysis of the let-7c top hits showed an enrichment
for genes involved in cell cycle checkpoint regulation,
while a similar analysis for miR-221 revealed a relationship
with genes involved in negative regulation of muscle
differentiation (Additional file 3: Table S3).
In addition, out of the 25 genes involved in the
RAS pathway, our screen identified 7 genes directly
targeted by let-7c (RhoB, PAK1, PAK3, BRAF, NFKBIA,
BCL2L1, KIT), suggesting a role for let-7c in regulating
this pathway.
Conclusion
3′UTRs contain powerful regulatory elements that are
critical in various biological processes, yet remain poorly
characterized because due to the absence of genomic
tools that allow their systematic study. In this work we
have prepared the first human 3′UTR clone collection
named h3′UTRome v1, which is produced to a single
high quality standard. This library is compatible with the
cloning technology used to produce the human ORFeome,
expanding the potential of well-established operating
methods for high throughput experimentation. The h3′
UTRome v1 library is sequence verified, and readily avail-
able to the community with simple online access to infor-
mation through the DNASU repository [53], at a low cost
to all scientists with minimal restriction. In order to
demonstrate its utility, we performed a screen with 87
human 3′UTRs cherry picked from the h3′UTRome
v1, and rapidly identified 27 miRNA targets for two
disease-relevant miRNAs, let-7c and miR-221. Within
this pool, we identified 18 novel targets for these two
miRNAs, which were previously uncharacterized (67 %).
In addition, we were able to eliminate 9 out of 18 bioinfor-
matically predicted targets (50 % false positive), and
rapidly associate miRNA activities to biological pathways
using a rapid screening technology.
The h3′UTRome v1 can be easily used in similar HT
experiments to systematically study RBP targeting in 3′
UTRs, mRNA localization and the role of small ncRNAs
in post transcriptional gene regulation.
Methods
Primer design
DNA primer sequences were designed using custom Perl
scripts using the annotated 3′UTR sequences in the
Human Genome release 19 (Additional file 1: Table S1)
(GRCh37/hg19 Feb. 2009) [19]. The forward primers
were anchored upstream of the last exon of each gene
and included the gene specific endogenous STOP co-
dons in frame with the ORFome library (Fig. 1). The
reverse primers were designed to target sites 150 nt
downstream of the longest annotated transcript, as per
the RefSeq annotation, in order to include downstream
3′end processing elements (Fig. 1). Forward and reverse
primers were fused to the attB2 (5′-GGGGACAGCT
TTCTTGTACAAAGTGGAG-3′) and attB3 (5′-GGG
GACAACTTTGTATAATAAAGTTG-3′) Gateway® se-
quences to allow modular cloning into pDONR P2rP3
Entry vectors. The full list of primers used is available
as (Additional file 1: Table S1) and through DNASU
(https://dnasu.org/DNASU) [53]. The first release of
the h3′UTRome V1 targeted a panel of 1,815 3′UTRs
(Fig. 1) enriched for transcription factors, kinases, RNA
binding protein and other regulatory genes. The length of
the 3′UTRs cloned in this release ranges between 200 and
2,500 nt in length, which is larger than the average size of
human 3′UTRs (Fig. 2).
Genomic DNA
We used the NA12878 DNA sample obtained from the
NIGMS Human Genetic Cell Repository at the Coriell
Institute for Medical Research (Camden, New Jersey).
This genomic DNA was extracted from the GM12878, a
B-lymphocyte cell line of a human female subject. Once
received, the genomic DNA was diluted to a concentra-
tion of 200 ng/μl, aliquoted in 96-well PCR reactions,
and stored at -80 °C until use.
Genomic touchdown PCR
The reactions were conducted using Platinum Taq poly-
merase (Invitrogen) in 96-well plates using 200 ng of gen-
omic DNA per reaction. The reaction conditions were
maintained as per the manufacturers protocol with changes
to the annealing temperature of the reaction. The PCR
conditions included 16 cycles of touchdown PCR, where
the temperature of the annealing phase decreased by 1 °C
per cycle, ending at a temperature of 50 °C. The reaction
proceeded for 15 more cycles at an annealing temperature
of 55 °C. The resulting PCR products were visualized
on by electrophoresis on 96-well agarose gels and screened
by size to determine successful amplicons.
Gateway® BP recombination reaction and transformation
Site-specific DNA recombination was used to clone the
human 3′UTR PCR amplicons into the Gateway® Entry
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vector pDONR P2r-P3 (Invitrogen), using BP Clonase II
Enzyme Mix kit (Invitrogen, Carlsbad, CA) following the
manufacturer’s specifications. DH5α E. coli cells were
transformed with 1 μl of the resultant reaction mixture,
and screened the following day for successful recombinants
using Lysogeny Broth (LB) agar plates with Kanamycin
(Kan) antibiotic.
3′UTR isolation and size screening
In order to isolate single clonal populations, unique bac-
terial colonies for each 3′UTR clone were picked from
the LB plates, and grown overnight in 96 deep-well
plates containing LB (500 mL) with Kanamycin resist-
ance (50 μg/mL) (total colonies picked = 1,824). The re-
sultant bacterial growths were used as a template to
perform colony PCR reactions using M13 DNA primer
pairs. The amplicons were then analyzed in 96-well agar-
ose gels and positive clones were initially screened based
on their expected size (Fig. 1d). Up to three more col-
onies for genes that did not satisfy our quality control
inspection were picked (total colonies picked = 753), and
rescreened by repeating the bacterial colony PCR step.
Bacterial colonies that passed the initial screen were re-
arrayed and stored in glycerol stocks, while the primer
pairs of the remaining genes were used in a second pass,
starting at genomic PCR to capture any 3′UTR missed
(Fig. 1c).
Sanger sequencing
PCR analysis with M13 DNA primer pairs was per-
formed for each positive 3′UTR clone, using overnight
bacterial growths as a template and Phusion® Taq poly-
merase (New England Biolabs), as per manufacturers
protocol. These PCR amplicons were then sent for
sequencing at the DNA Lab, School of Life Sciences,
Arizona State University, using the sequencing primer
1FP2rP3 seq (5′-GCATATGTTGTGTTTTACAGTATT
ATGTAG-3′) which binds ~100 nt upstream of the re-
combination element in the P2rP3 plasmid. 1,461 3′
UTR clones successfully sequence verified and passed
this step. The trace files for each 3′UTR clone success-
fully screened are available through DNAsu website [53].
Using custom a BioPerl script with Blat integration [21]
we mapped our sequencing results to 1,461 unique 3′
UTRs in the human genome.
3′LIFE screen
The 3′LIFE assay was performed as previously described
[18]. We re-arrayed bacterial colonies from a panel of
human 3′UTRs from the h3′UTRome v1, and grew the
plate over-night in a 96 deep-well format using 200 mL
of LB in presence of kanamycin (50 μg/mL). We used
1 μl of the resultant overnight culture to perform the
colony PCR with Phusion Taq polymerase (Invitrogen)
as per manufacturers protocol. The amplicons from the
PCR reaction were shuttled into the pLIFE-3′UTR vec-
tor (DNASU Plasmid ID: EvNO00601503) by LR recom-
bination using LR Clonase enzyme (Invitrogen) as per
manufacturers protocol. 1 μl of the resultant LR reaction
mixture was transformed in DH5ɑ E.coli cells. The
transformed cells were then plated on LB agar plates
containing ampicillin (100 μg/ml), and incubated over-
night at 37 °C. Single bacterial colonies were isolated
and grown overnight in 500 mL of LB containing ampi-
cillin (100 μg/mL). The resultant overnight bacterial
growth was screened based on size using agarose gel
electrophoresis. Bacterial colonies from wells passing the
screen were frozen as glycerol stocks and also grown
overnight for 96-well plasmid DNA extraction as previ-
ously described [8, 18]. In order to express let-7c miRNA
we used the pLIFE-miR let-7c construct [8, 18]. The
miRNA miR-221 was extracted from human genomic
DNA derived from GM12878 cells using DNA primers
containing Gateway® recombination elements (forward
primer – 5′-GGGGACAGCTTTCTTGTACAAAGTGG
AGTTTCAACATGATGTCATGATTAAATG-3′; reverse
primer- 5′-GGGGACAACTTTGTATAATAAAGTTGCA
CCTTATCTCTGGTTTACTAGGCTG-3′). The ampli-
fied PCR amplicon was cloned into pLIFE-miR (DNASU
Plasmid ID: EvNO00601504) vector using LR Clonase II
enzyme as per manufactures protocol (Invitrogen). We
designed the positive and negative controls for miR-221
targeting by introducing 22 nt long complementary se-
quences for the 3p arm (positive control) and 5p arm
(negative control) arms of miR-221 into the SV40 3′UTR
by site directed mutagenesis (Quikchange®, Invitrogen), as
per manufacturer protocol. We used the let-7c positive
control as previously described [8]. Plasmid DNA was ex-
tracted as was previously described [8]. The 3′LIFE assay
was performed as previously described [8, 18]. In brief, 87
queried human 3′UTRs + 3 controls were transfected into
HEK293T cells using the 96-well Shuttle nucleofection
system (Lonza). Transfected cells were cultured for 72 h
and then lysed, then used to perform the dual luciferase
assay. The screen was performed five times (435 reac-
tions), and the resulting data was analyzed as previously
described [8, 18]. The top hits for each miRNA were
distinguished by requiring a minimum repression index of
0.8 and a p-value < 0.05.
Additional files
Additional file 1: Table S1. List of primers used in the h3′UTRome v1.
A unique RefSeq ID refers to each transcript. For each transcript listed the
table displays its given alias, the forward and reverse primer sequences
used for genomic PCR, the chromosome of origin and the length of the
cloned 3′UTR. The Entrez and Ensembl gene IDs are listed where
available. (PDF 391 kb)
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Additional file 2: Table S2. List of 3′UTRs from the h3′UTRome v1
clone library used in the 3′LIFE assay. Each 3′UTR is referred to by a
unique RefSeq ID and its Alias. The 3′UTRs were queried for predicted
binding by miR-221 and let-7c using three prediction software; TargetScan,
PicTar and DIANA tools [10–12]. Previously validated 3′UTR-miRNA interactions
are listed with reference PMIDs. The direct involvement of each gene in the
RAS pathway was established by using the GO [54] and KEGG [39] databases.
The following column indicates if a given 3′UTR was among the top hits in
the 3′LIFE screen for each miRNA. (PDF 37 kb)
Additional file 3: Table S3. Gene Ontology analysis of let-7c and miR-221
top hits. The top hits for let-7c and miR-221 were queried for enrichments in
biological processes. Only results with p < 0.05 are shown. The resulting
biological processes are sorted based on fold enrichment. (PDF 57 kb)
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